NCT06193005

Brief Summary

The goal of this observational study is to evaluate and analyze the influencing factors of the adaptive ability of young people, explore the impact of the interaction of environment and gene on the psychological adaptive ability of young people, incorporate the prediction model of the dynamic change of adaptive ability, build a standardized norm of young people's adaptive ability, and form a grading reference standard system. The main questions it aims to answer are:

  • What are most important influencing factors for the adaptive ability of young people?
  • How the environment and gene interact with each other on the psychological adaptive ability of young people?
  • Can we build a prediction model of the dynamic change of adaptive ability and form a grading reference standard system? Participants will support us with basic information data, adaptive ability assessment data, genetic testing data, brain image scanning data, and inflammatory indicators data. Then subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score. And the statistical analysis will be performed by the data analyst.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 5, 2024

Status Verified

December 1, 2023

Enrollment Period

3 months

First QC Date

December 11, 2023

Last Update Submit

December 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the Assessment of the Psychological Resillience

    Psychological Resillience was evaluated across multiple dimensions, including cognitive functioning, stress coping, psychological well-being, and personality traits, and was measured using internationally accepted scales. Psychological Resillience is measured using the Psychological Resilience Scale (CD-RISC), which consists of 25 items rated on a 5-point Richter's scale, with scores ranging from 0 to 4 indicating that this is not the case at all, seldom the case, sometimes the case, often the case, and almost always the case. The sum of the scores of the items is the total score of the scale, and the total score is 0\~100, the larger the score indicates the higher the level of psychological resilience, and the score of less than 60 is the poor level of psychological resilience, 61\~69 is the average level of psychological resilience, 70\~79 is the good level of psychological resilience, and \>=80 is the excellent level of psychological resilience.

    1 year

Study Arms (4)

very low adaptive group

The subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.

Other: no intervention

low adaptive group

The subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.

Other: no intervention

high adaptive group

The subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.

Other: no intervention

very high adaptive group

The subjects were divided into very low adaptive group, low adaptive group, high adaptive group and very high adaptive group according to the quartile of adaptive ability score.

Other: no intervention

Interventions

no intervention

high adaptive grouplow adaptive groupvery high adaptive groupvery low adaptive group

Eligibility Criteria

Age18 Years - 24 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

18-24 years old young people

You may qualify if:

  • Age 18-24 years old; high school graduation and above; agree to collect blood samples and sign an informed consent form.

You may not qualify if:

  • Did not consent to the collection of blood samples; did not sign an informed consent form; suffered from a major illness such as a malignant tumor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Greenberg RL, Guzick AG, Schneider SC, Weinzimmer SA, Kook M, Perozo Garcia AB, Storch EA. Depressive Symptoms in Autistic Youth with Anxiety Disorders. J Dev Behav Pediatr. 2023 Dec 1;44(9):e597-e603. doi: 10.1097/DBP.0000000000001223. Epub 2023 Oct 11.

    PMID: 38019467BACKGROUND
  • Brunette MF, Erlich MD, Edwards ML, Adler DA, Berlant J, Dixon L, First MB, Oslin DW, Siris SG, Talley RM. Addressing the Increasing Mental Health Distress and Mental Illness Among Young Adults in the United States. J Nerv Ment Dis. 2023 Dec 1;211(12):961-967. doi: 10.1097/NMD.0000000000001734.

    PMID: 38015186BACKGROUND
  • Wong WLE, Arathimos R, Lewis CM, Young AH, Dawe GS. Investigating the role of the relaxin-3/RXFP3 system in neuropsychiatric disorders and metabolic phenotypes: A candidate gene approach. PLoS One. 2023 Nov 15;18(11):e0294045. doi: 10.1371/journal.pone.0294045. eCollection 2023.

    PMID: 37967073BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Form of biological specimen storage: venous blood was collected on an empty stomach, 5 ml was placed in a blood collection tube containing procoagulant and 5 ml was placed in a blood collection tube containing anticoagulant. Blood and other non-tissue samples are stored in a refrigerator at -86°C. The identification of the stored samples is unique and does not contain any donor identification information; the unique code is automatically and randomly generated by the sample bank management system and consists of 18 digits.

MeSH Terms

Conditions

Genetic Predisposition to DiseaseInflammation

Condition Hierarchy (Ancestors)

Disease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Guang Zhang, Dr

    Qianfoshan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wenqi Hu, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice President

Study Record Dates

First Submitted

December 11, 2023

First Posted

January 5, 2024

Study Start

January 1, 2024

Primary Completion

March 31, 2024

Study Completion

December 31, 2024

Last Updated

January 5, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.